News
In Practice: RACGP future governance consultation
Members have an opportunity to provide feedback on the future direction of the college, ahead of this year’s AGM.
Ahead of the 2026 AGM, RACGP members can provide feedback on the future direction of the college.
This week’s In Practice includes details about a new national clinical governance model, resources to help GPs support older patients accessing the Support at Home program, and CPD events on infant food allergies and sexual wellbeing.
Help shape the future governance of the RACGP
Webinar: Thursday 11 June, 8.00 pm (AEST)
Register online
RACGP members are invited to attend a Future Governance Committee consultation session via Zoom on Thursday 11 June.
In this session, members will hear more about proposed governance changes ahead of the 2026 Annual General Meeting and can provide feedback on the future direction of the college.
Members can review the proposed changes and submit feedback via the Future Governance webpage or by emailing companysecretary@racgp.org.au.
New clinical governance model
The Australian Commission on Safety and Quality in Health Care (ACSQHC) has released the National Model for Clinical Governance.
In developing the national model, the ACSQHC reviewed the latest evidence and consulted with health system leaders and clinicians across Australia to understand gaps in capability and delivery, and what high-performing organisations do differently. The national model represents a significant change in how clinical governance is understood, led and embedded in acute health services.
A range of implementation resources to support health services and clinicians to use the national model is available on the ACSQHC website.
New Support at Home resources for GPs
The Department of Health, Disability and Ageing (DoHDA) has released new resources to help GPs support older patients accessing the Support at Home program.
The resources include guidance on referral pathways, urgent referrals, reassessments and the End-of-Life Pathway for eligible patients with less than three months to live who wish to remain at home.
Support at Home replaced the Home Care Packages Program and Short-Term Restorative Care Program in November 2025. The program aims to help older people remain healthy, active and connected to their community while living at home.
Members can access the full suite of resources, guidance and referral information via the DoHDA’s Support at Home website.
Delayed food reactions in infants
Webinar: Thursday 11 June, 7.30 – 8.30 pm (AEST)
CPD: 1 EA hour
Register online
This webinar provides a concise, evidence-based overview of non-IgE mediated food allergies in infancy, focusing on cow’s milk protein allergy (CMPA), food protein-induced allergic proctocolitis (FPIAP), and food protein-induced enterocolitis syndrome (FPIES).
Designed for primary care clinicians, this session aims to support accurate diagnosis, reduce variability in care, and promote safe, practical management aligned with current evidence. Key topics include:
- clinical presentations across CMPA, FPIAP, and FPIES
- differentiating features and spectrum of disease
- structured approach to assessment and diagnosis
- use of elimination diets and monitoring response
- timing and approach to reintroduction
- indications for specialist referral
- common pitfalls, including overdiagnosis and unnecessary dietary restriction.
Cultivating deep desire for intimacy – why testosterone is not a quick fix
Webinar: Wednesday 10 June, 7.30 – 8.30 pm (AEST)
CPD: 1 EA hour
Register online
This webinar will explore why sexual wellbeing is a health issue and the differential diagnosis of low libido and approach to the diagnosis of low libido.
The session will discuss trauma-informed and sex-positive approaches to sexual history taking, including the
PLISSIT model, and will also provide practical approach for assessing the bio-psycho-social contributors to sexual arousal/desire.
Log in below to join the conversation.
clinical governance food allergies governance older patients sexual wellbeing Support at Home program
newsGP weekly poll
Do you have patients who will be impacted by a decision to pull low-dose goserelin (sold as Zoladex) from the Australian market in November?